Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial

International Journal of Behavioral Nutrition and Physical Activity

Giel Nijpels³  Jacqueline M Dekker¹  Piet J Kostense¹  Maurits W van Tulder⁴  Mai J Chinapaw²  Sandra D Bot¹  Jeroen Lakerveld³ 

[1] Department of Epidemiology & Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Center, van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands;Department of Public and Occupational Health and the EMGO Institute for Health and Care Research, VU University Medical Center, van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands;Department of General Practice and the EMGO Institute for Health and Care Research, VU University Medical Center, van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands;Health Sciences and the EMGO Institute for Health and Care Research, VU University Medical Center, van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands

关键词: Overweight;    Lifestyle;    Smoking;    Dietary behavior;    Physical activity;    Prevention;    Cardiovascular disease;    Type 2 diabetes;   

Others  :  810451
DOI  :  10.1186/1479-5868-10-47

 received in 2012-05-19, accepted in 2013-04-16,  发布年份 2013

【 摘 要 】

Background

Intensive lifestyle interventions in well-controlled settings are effective in lowering the risk of chronic diseases such as type 2 diabetes (T2DM) and cardiovascular diseases (CVD), but there are still no effective lifestyle interventions for everyday practice. In the Hoorn Prevention Study we aimed to assess the effectiveness of a primary care based lifestyle intervention to reduce the estimated risk of developing T2DM and for CVD mortality, and to motivate changes in lifestyle behaviors.

Methods

The Hoorn Prevention Study is a parallel group randomized controlled trial, implemented in the region of West-Friesland, the Netherlands. 622 adults with ≥10% estimated risk of T2DM and/or CVD mortality were randomly assigned and monitored over a period of 12 months. The intervention group (n=314) received a theory-based lifestyle intervention based on an innovative combination of motivational interviewing and problem solving treatment, provided by trained practice nurses in 12 general practices. The control group (n=308) received existing health brochures. Primary outcomes was the estimated diabetes risk according to the formula of the Atherosclerosis Risk In Communities (ARIC) Study, and the estimated risk for CVD mortality according to the Systematic COronary Risk Evaluation (SCORE) formula. Secondary outcomes included lifestyle behavior (diet, physical activity and smoking). The research assistants, the principal investigator and the general practitioners were blinded to group assignment. Linear and logistic regression analysis was applied to examine the between-group differences in each outcome measure, adjusted for baseline values.

Results

536 (86.2%) of the 622 participants (age 43.5 years) completed the 6-month follow-up, and 502 (81.2%) completed the 12-month follow-up. The mean baseline T2DM risk was 18.9% (SD 8.2) and the mean CVD mortality risk was 3.8% (SD 3.0). The intervention group participated in a median of 2 sessions. Intention-to-treat analyses showed no significant differences in outcomes between the two groups at 6 or 12-months follow-up.

Conclusions

The lifestyle intervention was not more effective than health brochures in reducing risk scores for T2DM and CVD or improving lifestyle behavior in an at-risk population.

Trial registration

Current Controlled Trials: ISRCTN59358434

【 授权许可】

   
2013 Lakerveld et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev 1995, 75:473-486.
• [2]Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J: Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007, 298:2654-2664.
• [3]Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 2004, 364:937-952.
• [4]Horton ES: Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: results from large scale efficacy trials. Obesity (Silver Spring) 2009, 17(Suppl 3):S43-S48.
• [5]Yates T, Davies M, Khunti K: Preventing type 2 diabetes: can we make the evidence work? Postgrad Med J 2009, 85:475-480.
• [6]Goyder EC: Screening for and prevention of type 2 diabetes. BMJ 2008, 336:1140-1141.
• [7]Marrero DG: The prevention of type 2 diabetes: an overview. J Diabetes Sci Technol 2009, 3:756-760.
• [8]Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG: Translating the diabetes prevention program into the community. The DEPLOY pilot study. Am J Prev Med 2008, 35:357-363.
• [9]Eriksson MK, Franks PW, Eliasson M: A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Bjorknas study. PLoS One 2009, 4:e5195.
• [10]Kinmonth AL, Wareham NJ, Hardeman W, Sutton S, Prevost AT, Fanshawe T: Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial. Lancet 2008, 371:41-48.
• [11]Koelewijn-van Loon MS, van der Weijden T, van Steenkiste B, Ronda G, Winkens B, Severens JL: Involving patients in cardiovascular risk management with nurse-led clinics: a cluster randomized controlled trial. CMAJ 2009, 181:E267-E274.
• [12]van Sluijs EM, van Poppel MN, Twisk JW, Chinapaw MJM, Calfas KJ, van Mechelen W: Effect of a tailored physical activity intervention delivered in general practice settings: results of a randomized controlled trial. Am J Public Health 2005, 95:1825-1831.
• [13]Vermunt PW, Milder IE, Wielaard F, de Vries JH, van Oers HA, Westert GP: Lifestyle counseling for type 2 diabetes risk reduction in dutch primary care: results of the APHRODITE study after 0.5 and 1.5 years. Diabetes Care 2011, 34(9):1919-1925.
• [14]Yates T, Davies MJ, Sehmi S, Gorely T, Khunti K: The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years? Diabet Med 2011, 28:1268-1271.
• [15]Laatikainen T, Dunbar JA, Chapman A, Kilkkinen A, Vartiainen E, Heistaro S: Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) diabetes prevention project. BMC Public Health 2007, 7:249. BioMed Central Full Text
• [16]Absetz P, Oldenburg B, Hankonen N, Valve R, Heinonen H, Nissinen A: Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial. Diabetes Care 2009, 32:1418-1420.
• [17]Kraushaar LE, Kramer A: Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health 2009, 9:64. BioMed Central Full Text
• [18]Ware JH, Hamel MB: Pragmatic trials–guides to better patient care? N Engl J Med 2011, 364:1685-1687.
• [19]Lakerveld J, Bot S, Chinapaw M, van Tulder M, van Oppen P, Dekker J: Primary prevention of diabetes mellitus type 2 and cardiovascular diseases using a cognitive behavior program aimed at lifestyle changes in people at risk: Design of a randomized controlled trial. BMC Endocrine Disorders 2008, 8:6. BioMed Central Full Text
• [20]Baan CA, van Baal PHM, Jacobs-van der Bruggen M, Verkley H, Poos MJJC, Hoogenveen RT: [Diabetes mellitus in the Netherlands: estimate of the current disease burden and prognosis for 2025]. Ned Tijdschr Geneeskd 2009, 153:A580.
• [21]Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH: Identifying individuals at high risk for diabetes - The Atherosclerosis risk in communities study. Diabetes Care 2005, 28:2013-2018.
• [22]Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
• [23]Ajzen I: From intentions to action: A theory of Planned behavior. In Action-control: From cognition to behavior. New York: Springer; 1985.
• [24]Leventhal H, Nerenz DR, Straus A: Self-regulation and the mechanisms for symptomappraisal. Edited by Mechanic D. New York: Symptoms, Illness Behavior and Help-Seeking, Prodist; 1982:55-86. 3
• [25]Welschen L, van Oppen P, Bot S, Kostense P, Dekker J, Nijpels G: Effects of a cognitive behavioural treatment in patients with type 2 diabetes when added to managed care; a randomised controlled trial. J Behav Med 2012,  .
• [26]Miller WR, Rollnick S: Motivational Interviewing: preparing people for change. 2nd edition. New York, London: Guilford Press; 2002.
• [27]Mynors-Wallis LM: Problem-solving treatment in general psychiatric practice. Adv Psychiatr Treat 2001, 7:417-425.
• [28]Ainsworth BE, Haskell WL, Leon AS, Jacobs DRJ, Montoye HJ, Sallis JF: Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993, 25:71-80.
• [29]Saris WH, Blair SN, van Baak MA, Eaton SB, Davies PS, Di PL: How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes Rev 2003, 4:101-114.
• [30]Wendel-Vos GC, Schuit AJ, Saris WH, Kromhout D: Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol 2003, 56:1163-1169.
• [31]Bogers RP, van Assema P, Kester AD, Westerterp KR, Dagnelie PC: Reproducibility, validity, and responsiveness to change of a short questionnaire for measuring fruit and vegetable intake. Am J Epidemiol 2004, 159:900-909.
• [32]World Health Organization (WHO): Guidelines for controlling and monitoring the tobacco epidemic. Geneva: WHO monograph no WM 290 98GU; 1998.
• [33]van Wier M, Ariens G, Dekkers J, Hendriksen I, Pronk N, Smid T: ALIFE@Work: a randomised controlled trial of a distance counselling lifestyle programme for weight control among an overweight working population [ISRCTN04265725]. BMC Public Health 2006, 6:140. BioMed Central Full Text
• [34]Lakerveld J, Brug J, Bot S, Teixeira P, Rutter H, Woodward E: Sustainable prevention of obesity through integrated strategies: The SPOTLIGHT project's conceptual framework and design. BMC Public Health 2012, 12:793. BioMed Central Full Text
• [35]Malouff JM, Thorsteinsson EB, Schutte NS: The efficacy of problem solving therapy in reducing mental and physical health problems: a meta-analysis. Clin Psychol Rev 2007, 27:46-57.
• [36]Rubak S, Sandboek A, Lauritzen T, Christensen B: Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract 2005, 55:305-312.
• [37]Cardona-Morrell M, Rychetnik L, Morrell SL, Espinel PT, Bauman A: Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health 2010, 10:653. BioMed Central Full Text
• [38]Simmons RK, Unwin N, Griffin SJ: International diabetes federation: an update of the evidence concerning the prevention of type 2 diabetes. Diabetes Res Clin Pract 2010, 87:143-149.
• [39]Lakerveld J, Bot S, Chinapaw M, van Tulder M, Kingo L, Nijpels G: Process evaluation of a lifestyle intervention to prevent diabetes and cardiovascular diseases in primary care. Health Promot Pract 2012, 13:696-706.
• [40]Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
• [41]Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX: Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance - The Da Qing IGT and diabetes study. Diabetes Care 1997, 20:537-544.
• [42]Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
• [43]Lakerveld J, IJzelenberg W, van Tulder MW, Hellemans IM, Rauwerda JA, van Rossum AC: Motives for (not) participating in a lifestyle intervention trial. BMC Med Res Methodol 2008, 8:17. BioMed Central Full Text
• [44]Dillman DA: Mail and Internet Surveys: The Tailored Design Method. 2nd edition. New York: John Wiley and Sons; 2000.